Ivermectin, a potential anticancer drug derived from an …
www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer …
Ivermectin has New Application in Inhibiting Colorectal …
pubmed.ncbi.nlm.nih.gov/34483925/Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown …
Ivermectin has New Application in Inhibiting Colorectal …
www.ncbi.nlm.nih.gov/pmc/articles/PMC8415024/Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown …
The multitargeted drug ivermectin: from an antiparasitic …
www.ncbi.nlm.nih.gov/pmc/articles/PMC5835698/Ivermectin modifies the epigenetic signature and the self-renewal activity in the malignant cell due to its ability to mimic the SIN3-interaction that …
Ivermectin as an inhibitor of cancer stem‑like cells
pubmed.ncbi.nlm.nih.gov/29257278/The aim of the present study was to demonstrate that ivermectin preferentially inhibited cancer stem‑like cells (CSC) in breast cancer cells and …
Anti-parasite drug ivermectin can suppress ovarian cancer …
www.ncbi.nlm.nih.gov/pmc/articles/PMC7272521/Ivermectin, as an old anti-parasite drug, can suppress almost completely the growth of various human cancers, including ovarian cancer (OC). However …
Antitumor effects of ivermectin at clinically feasible …
pubmed.ncbi.nlm.nih.gov/32474842/Purpose: Ivermectin is an antiparasitic drug that exhibits antitumor effects in preclinical studies, and as such is currently being repositioned for c …
Anti-parasite drug ivermectin can suppress ovarian cancer …
pubmed.ncbi.nlm.nih.gov/32549918/Relevance: Ivermectin, as an old anti-parasite drug, can suppress almost completely the growth of various human cancers, including ovarian cancer …
Antibiotic ivermectin preferentially targets renal cancer …
pubmed.ncbi.nlm.nih.gov/28847725/Renal cell carcinoma (RCC) is the most aggressive type of genitourinary cancer and highly resistant to current available therapies. In this work, we …
National Cancer Institute
www.cancer.gov/publications/dictionaries/cancer-drug/def/ivermectinFind technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry …
Ivermectin: a systematic review from antiviral effects to …
pubmed.ncbi.nlm.nih.gov/32533071/Ivermectin proposes many potentials effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder …
Ivermectin induces apoptosis of esophageal squamous cell …
www.ncbi.nlm.nih.gov/pmc/articles/PMC8650430/Taken together, these data suggest that ivermectin inhibits the growth of esophageal cancer both in vitro and in vivo. It had been reported that iverm …
National Cancer Institute
www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/ivermectinFrederick National Laboratory for Cancer Research . Bioinformatics, Big Data, and Cancer. Key Initiatives. Progress. Annual Report to the Nation …
Ivermectin inactivates the kinase PAK1 and blocks the PAK1 …
pubmed.ncbi.nlm.nih.gov/22495656/Ivermectin is an old anti-parasitic antibiotic which selectively kills nematodes at a very low dose (0.2 mg/kg) by inhibiting their GABA …
The river blindness drug Ivermectin and related …
www.ncbi.nlm.nih.gov/pmc/articles/PMC4287931/Ivermectin inhibits lung cancer xenograft growthin vivo. Beyond colon cancer, WNT-TCF signaling has been implicated in a number of other tumor types …
Doxycycline, salinomycin, monensin and ivermectin …
pubmed.ncbi.nlm.nih.gov/31054863/Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs Bioorg Med Chem Lett. 2019 Jul 1;29(13):1549-1554. doi …
Ivermectin converts cold tumors hot and synergizes with …
pubmed.ncbi.nlm.nih.gov/33654071/We show that treatment with the FDA-approved anti-parasitic drug ivermectin induces immunogenic cancer cell death (ICD) and robust T cell infiltration …
Ivermectin Induces Cytostatic Autophagy by Blocking the …
pubmed.ncbi.nlm.nih.gov/27302166/Breast cancer is the most common cancer among women worldwide, yet successful treatment remains a clinical challenge. Ivermectin, a broad-spectrum …
Progress in Understanding the Molecular Mechanisms …
www.ncbi.nlm.nih.gov/pmc/articles/PMC6982461/Ivermectin causes cell death in cancer cell lines by inducing PAK1-mediated cytostatic autophagy, caspase-dependent apoptosis and immunogenic cell …
Ivermectin inhibits canine mammary tumor growth by …
www.ncbi.nlm.nih.gov/pmc/articles/PMC6679554/Ivermectin inhibited the proliferation of cancer cells (Fig. 1 a and b) with less effects on a normal canine epithelial cell line (Fig. 1 d), which …